204 related articles for article (PubMed ID: 37254902)
1. Intratumoral injection therapies for locally advanced pancreatic cancer: systematic review.
Willink CY; Jenniskens SFM; Klaassen NJM; Stommel MWJ; Nijsen JFW
BJS Open; 2023 May; 7(3):. PubMed ID: 37254902
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Isotope selection for patients undergoing prostate brachytherapy.
Cha CM; Potters L; Ashley R; Freeman K; Wang XH; Waldbaum R; Leibel S
Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):391-5. PubMed ID: 10487561
[TBL] [Abstract][Full Text] [Related]
4. Preliminary toxicity and prostate-specific antigen response of a Phase I/II trial of neoadjuvant hormonal therapy, 103Pd brachytherapy, and three-dimensional conformal external beam irradiation in the treatment of locally advanced prostate cancer.
Stock RG; Stone NN
Brachytherapy; 2002; 1(1):2-10. PubMed ID: 15062181
[TBL] [Abstract][Full Text] [Related]
5. Intraoperative radiotherapy in the combined-modality management of pancreatic cancer.
Schuricht AL; Spitz F; Barbot D; Rosato F
Am Surg; 1998 Nov; 64(11):1043-9. PubMed ID: 9798766
[TBL] [Abstract][Full Text] [Related]
6. Systematic review of innovative ablative therapies for the treatment of locally advanced pancreatic cancer.
Rombouts SJ; Vogel JA; van Santvoort HC; van Lienden KP; van Hillegersberg R; Busch OR; Besselink MG; Molenaar IQ
Br J Surg; 2015 Feb; 102(3):182-93. PubMed ID: 25524417
[TBL] [Abstract][Full Text] [Related]
7. [Intraoperative 125I brachytherapy combined with chemotherapy for pancreatic cancer].
Wang DM; Liu YH; Yu SP; Duan XN; Yang YM; Wan YL; Zhou G; Shen WJ
Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):433-6. PubMed ID: 15355651
[TBL] [Abstract][Full Text] [Related]
8. Edema-induced increase in tumour cell survival for 125I and 103Pd prostate permanent seed implants--a bio-mathematical model.
Yue N; Chen Z; Nath R
Phys Med Biol; 2002 Apr; 47(7):1185-204. PubMed ID: 11996063
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Image-Guided Iodine-125 Seed Interstitial Brachytherapy and Local Chemotherapy Perfusion in Treatment of Advanced Pancreatic Cancer.
Zhou L; Yang H; Xie L; Sun J; Qian J; Zhu L
J Invest Surg; 2022 Jan; 35(1):1-6. PubMed ID: 32865062
[TBL] [Abstract][Full Text] [Related]
10. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy with various seed models.
Thomson RM; Rogers DW
Med Phys; 2010 Jan; 37(1):368-76. PubMed ID: 20175499
[TBL] [Abstract][Full Text] [Related]
11. Seed fixity in the prostate/periprostatic region following brachytherapy.
Merrick GS; Butler WM; Dorsey AT; Lief JH; Benson ML
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):215-20. PubMed ID: 10656395
[TBL] [Abstract][Full Text] [Related]
12. Feasibility study of the treatment of primary unresectable carcinoma of the pancreas with 103Pd brachytherapy.
Raben A; Mychalczak B; Brennan MF; Minsky B; Anderson L; Casper ES; Harrison LB
Int J Radiat Oncol Biol Phys; 1996 May; 35(2):351-6. PubMed ID: 8635943
[TBL] [Abstract][Full Text] [Related]
13. Cryosurgery with combination of (125)iodine seed implantation for the treatment of locally advanced pancreatic cancer.
Xu KC; Niu LZ; Hu YZ; He WB; He YS; Zuo JS
J Dig Dis; 2008 Feb; 9(1):32-40. PubMed ID: 18251792
[TBL] [Abstract][Full Text] [Related]
14. Optimum timing for image-based dose evaluation of 125I and 103PD prostate seed implants.
Yue N; Chen Z; Peschel R; Dicker AP; Waterman FM; Nath R
Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):1063-72. PubMed ID: 10571216
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of gemcitabine plus erlotinib for locally advanced or metastatic pancreatic cancer: a systematic review and meta-analysis.
Wang Y; Hu GF; Zhang QQ; Tang N; Guo J; Liu LY; Han X; Wang X; Wang ZH
Drug Des Devel Ther; 2016; 10():1961-72. PubMed ID: 27358556
[TBL] [Abstract][Full Text] [Related]
16. Complete remission of nonresectable pancreatic cancer after infusional colloidal phosphorus-32 brachytherapy, external beam radiation therapy, and 5-fluorouracil: a preliminary report.
DeNittis AS; Stambaugh MD; Lang P; Wallner PE; Lustig RA; Dillman RO; Order SE
Am J Clin Oncol; 1999 Aug; 22(4):355-60. PubMed ID: 10440189
[TBL] [Abstract][Full Text] [Related]
17. Endoscopic ultrasound-guided injectable therapy for pancreatic cancer: A systematic review.
Kaur J; Jaruvongvanich V; Chandrasekhara V
World J Gastroenterol; 2022 Jun; 28(21):2383-2395. PubMed ID: 35800184
[TBL] [Abstract][Full Text] [Related]
18. A Phase I clinical trial of EUS-guided intratumoral injection of the oncolytic virus, HF10 for unresectable locally advanced pancreatic cancer.
Hirooka Y; Kasuya H; Ishikawa T; Kawashima H; Ohno E; Villalobos IB; Naoe Y; Ichinose T; Koyama N; Tanaka M; Kodera Y; Goto H
BMC Cancer; 2018 May; 18(1):596. PubMed ID: 29801474
[TBL] [Abstract][Full Text] [Related]
19. Endoscopic ultrasonography-guided interstitial implantation of iodine 125-seeds combined with chemotherapy in the treatment of unresectable pancreatic carcinoma: a prospective pilot study.
Jin Z; Du Y; Li Z; Jiang Y; Chen J; Liu Y
Endoscopy; 2008 Apr; 40(4):314-20. PubMed ID: 18283622
[TBL] [Abstract][Full Text] [Related]
20. Surgical resection rates after neoadjuvant therapy for localized pancreatic ductal adenocarcinoma: meta-analysis.
Brown ZJ; Heh V; Labiner HE; Brock GN; Ejaz A; Dillhoff M; Tsung A; Pawlik TM; Cloyd JM
Br J Surg; 2022 Dec; 110(1):34-42. PubMed ID: 36346716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
